These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9519625)

  • 21. Is it acceptable for people to take methylphenidate to enhance performance? No.
    Chatterjee A
    BMJ; 2009 Jun; 338():b1956. PubMed ID: 19541706
    [No Abstract]   [Full Text] [Related]  

  • 22. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate induction of complex visual hallucinations.
    Halevy A; Shuper A
    J Child Neurol; 2009 Aug; 24(8):1005-7. PubMed ID: 19502578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 26. [Paradoxical effect of methylphenidate in the treatment of a patient with severe traumatic brain injury].
    Grønborg P; Liljegren J; Jansen J
    Ugeskr Laeger; 2009 Jun; 171(26):2201-2. PubMed ID: 19671403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis).
    Staton RD; Brumback RA
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):427-8. PubMed ID: 6108320
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Movement disorders induced by neuroleptic therapy].
    Almeida R; Santos MV
    Acta Med Port; 1993 Jun; 6(6):239-44. PubMed ID: 8103618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse Maculopapular Rash With Increasing Dosage of Methylphenidate.
    Kaya I; Coskun M
    J Clin Psychopharmacol; 2016 Feb; 36(1):106-7. PubMed ID: 26658080
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R; Banaschewski T; Becker K
    Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia in patients receiving lithium maintenance therapy.
    Perényi A; Szücs R; Frecska E
    Biol Psychiatry; 1984 Nov; 19(11):1573-8. PubMed ID: 6151403
    [No Abstract]   [Full Text] [Related]  

  • 33. A washout period needed before switching from a neuroleptic to an amphetamine.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate-induced obsessive-compulsiveness.
    Kouris S
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):135. PubMed ID: 9473905
    [No Abstract]   [Full Text] [Related]  

  • 35. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
    Zetterström R
    Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of tardive dyskinesia.
    Tepper SJ; Haas JF
    J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tactile hallucinations with fluoxetine and methylphenidate.
    Arora GS; Arora HK; Sidhu J; Najjar F
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):360-1. PubMed ID: 25007312
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardiovascular side effects secondary to treatment with methylphenidate].
    Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
    Rev Neurol; 2010 May; 50(9):573-4. PubMed ID: 20443179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.